Is Lasmiditan Succinate Tablet (Reyvow) in shortage?
Lasmiditan Succinate Tablet is listed by FDA as being discontinued by at least one maker (updated Nov 3, 2025).
Every listed package
FDA tracks shortages per package. What each maker reports, most recently updated first:
- Reyvow, Tablet, 50 mg (NDC 0002-4312-08)
A business decision was made to discontinue manufacture of the 50 mg and 100 mg tablets. Distribution will end on May 31, 2026.
Maker contact: 800-545-5979
- Reyvow, Tablet, 50 mg (NDC 0002-4312-61)
A business decision was made to discontinue manufacture of the 50 mg and 100 mg tablets. Distribution will end on May 31, 2026.
Maker contact: 800-545-5979
- Reyvow, Tablet, 50 mg (NDC 0002-4312-62)
A business decision was made to discontinue manufacture of the 50 mg and 100 mg tablets. Distribution will end on May 31, 2026.
Maker contact: 800-545-5979
- Reyvow, Tablet, 100 mg (NDC 0002-4491-08)
A business decision was made to discontinue manufacture of the 50 mg and 100 mg tablets. Distribution will end on May 31, 2026.
Maker contact: 800-545-5979
- Reyvow, Tablet, 100 mg (NDC 0002-4491-61)
A business decision was made to discontinue manufacture of the 50 mg and 100 mg tablets. Distribution will end on May 31, 2026.
Maker contact: 800-545-5979
- Reyvow, Tablet, 100 mg (NDC 0002-4491-62)
A business decision was made to discontinue manufacture of the 50 mg and 100 mg tablets. Distribution will end on May 31, 2026.
Maker contact: 800-545-5979
Lasmiditan Succinate Tablet shortage questions
Is Lasmiditan Succinate Tablet (Reyvow) in shortage?
Lasmiditan Succinate Tablet is listed by FDA as being discontinued by at least one maker (updated Nov 3, 2025).
What should I do if I can’t get Lasmiditan Succinate Tablet?
Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.
Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.